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Abstract 
We present a new methodology for the generation of discrete molecularly-dispersed enzyme–
polymer-surfactant bioconjugates. Significantly, we demonstrate that a more-than three-fold 
increase in the catalytic efficiency of the diffusion-limited phosphotriesterase arPTE can be 
achieved through sequential electrostatic addition of cationic and anionic  polymer surfactants, 
respectively. Here, the polymer surfactants assemble on the surface of the enzyme via ion 
exchange to yield a compact corona. The observed rate enhancement is consistent with a 
mechanism whereby the polymer-surfactant corona gives rise to a decrease in the dielectric 
constant in the vicinity of the active site of the enzyme, accelerating the rate-determining 
product diffusion step. The facile methodology has significant potential for increasing the 




Phosphotriesterases (PTEs, also known as organophosphate hydrolases) have evolved to 
rapidly detoxify organophosphates (OPs). This has attracted significant interest as a potential 
means to counteract poisoning from OP-based chemical warfare agents and pesticides.(1, 2) 
These highly toxic compounds are still used as a tool of conflict and covert action, with recent 
examples including sarin attacks in Syria and the use of a Novichock agent in the United 
Kingdom.(3) The effectiveness of PTEs are directly dependent on the rate at which they can 
detoxify these compounds, as well as the lifetime of the enzyme.(4) The real-world 
performance of enzymes can often be improved through covalent modifications such as 
PEGylation,(5, 6) or immobilization and entrapment of enzymes at surfaces.(7-9) Indeed, 
enzyme immobilization can offer great improvements to thermostability, enable enzymes to 
be integrated into large-scale high-throughput production systems, and crucially, allow these 
enzymes to be recycled multiple times.(10-12) However, these approaches often impart 
detrimental effects such as a decrease in enzyme activity, which can preclude an enzyme 
from practical use.(10, 11, 13, 14) Here, this decrease in activity can result from surface-
induced denaturation, obstruction of the active site, or reduction in the rate of substrate/ 
product diffusion.  
We have previously developed a methodology to modify protein surfaces via electrostatic 
assembly of a polymer surfactant corona.(15-18) This process involves chemical cationization 
via nucleophilic addition of diamines to the solvent-exposed acidic residues to generate super-
cationic proteins, followed by electrostatic grafting of anionic polymer surfactant molecules to 
the surface. Once formed, these complexes were ionically stable, as verified through analytical 




substrates such as lipids does not dissociate the enzyme-surfactant complex.(15) 
Significantly, the resulting hybrid constructs were used to produce a portfolio of new 
biomaterials that exhibited a wide range of interesting properties, including biologically-active 
solvent-free biofluids with extreme thermostability,(15, 17, 18) hierarchically self-assembled 
membranes films with recyclable catalytic activities,(20, 21) and artificial cell membrane-
binding proteins with oxygen delivery and extracellular matrix forming capacities.(22, 23) 
However, as commonly reported for other covalent approaches to protein modification, the 
chemical cationization required to supercharge the proteins resulted in a significant loss in 
protein structure and enzymatic activity.(15, 22, 24) Accordingly, we describe a non-covalent 
approach to generate molecularly dispersed protein–polymer surfactant bioconjugates 
(Figure 1). This new methodology involves sequential electrostatic grafting of PEG-based 
cationic and anionic surfactants via ion exchange to the naturally-occurring charged residues 
on the surface of the enzyme. This gives rise to monodispersed enzyme–polymer surfactant 
complexes (denoted [Enzyme][S+][S−]) that are analogous to previously described 
bioconjugates,(15, 22) but can be readily produced without the need for covalent modification. 
Significantly, for the Agrobacterium radiobacter phosphotriesterase (arPTE),(25) we observe 
a more-than three-fold increase in the catalytic efficiency by optimising the composition of the 






Figure 1. Schematic depicting the conjugation 
process, involving the sequential electrostatic addition 
of polymer-surfactants. First, cationic surfactants 
(Ethoquad, red) are complexed to an unmodified 
protein (arPTE shown above) through electrostatic 
forces to the solvent exposed anionic amino acids (red 
sites on the protein). This is then followed by the 
addition of an anionic surfactant (oxidized IGEPAL, 
blue), which are likewise complexed to the protein 
through electrostatic interactions with the solvent 
exposed cationic amino acids (blue sites on the 
protein). The result is a surfactant corona that 





Kinetic assays of paraoxon hydrolysis using [arPTE][S+][S−] were performed over a range of 
anionic polymer surfactant molecular weights, with higher molecular weight surfactants 
tending towards higher activities (Figure S1). Moreover, no activity enhancement was 
observed after the addition of only the cationic surfactant Ethoquad (Figure S1). Reversing 
the order of addition of the surfactants (i.e., [S−][S+]) for some surfactants resulted in enzyme 
aggregation and precipitation, and accordingly, was not pursued further. Previous 
computational models reveal the formation of micelle-like structures, which limits the 
interactions between the charged heads groups of the different surfactants and thus facilitates 
the formation of the corona despite the potential for surfactant-surfactant ionic 
interactions.(26) The greatest enhancement to catalytic activity occurred after the sequential 
addition of Ethoquad followed by oxidized IGEPAL-890 (Figures 2 and S2), which resulted in 
a two-fold increase in the substrate turnover rate (kcat) when compared to unmodified arPTE 
(267 ± 12 s-1 to 575 ± 23 s-1). Moreover, this was accompanied by an improvement in the 
substrate binding affinity (Km; 56 ± 10 to 36 ± 6 µM), which translates to a more-than three-
fold increase in the specificity constant (catalytic efficiency, kcat/Km; 4.7×106 to 1.6×107 M-1 S-
1). Accordingly, this protocol was used for all subsequent experiments, and the resulting 
bioconjugate is hereafter denoted by [arPTE][S+][S−].  
 
  
Figure 2. a) The Michaelis–Menten curve of 
the enzyme arPTE (blue) compared and 
[arPTE][S+][S−] (red) demonstrating a large 
increase to catalytic rate at room temperature. 
Assays were performed under the conditions 
described in the supplementary methods. b) 
The corresponding kcat and Km of arPTE and 
[arPTE][S+][S−] derived from the Michaelis–




To verify polymer-surfactant binding to the surface of arPTE, synchrotron radiation small angle 
X-ray scattering (SR-SAXS) experiments were performed to evaluate the dimensions of the 
unmodified and surfactant complexed enzyme ([arPTE][S+][S−]). A 12.6 Å increase in the radial 
average (rave) was calculated from the pair–distance distribution function (P(r), Figure 3A) of 
[arPTE][S+][S−] relative to arPTE, which is comparable to computational models based on the 
analogous chemically-cationized single-surfactant systems.(26) Additionally, there was a 
small change in the Porod exponent between arPTE and [arPTE][S+][S−] (3.8 to 3.5, Table 
S1), which is to be expected due to the addition of flexible surfactant chains. Bead models 
produced from the SR-SAXS analyses revealed that the size and the shape of the unmodified 
arPTE is commensurate with published crystal structures of the dimeric enzyme (PDB ID: 
2D2J), and that [arPTE][S+][S−] has an increased size corresponding to the addition of a 
compact polymer surfactant corona to the dimer (Figures 3B and S3A-B). This size increase 
supports an electrostatically-driven assembly process to form an encapsulating polymer 




Circular dichroism (CD) measurements revealed superimposable spectra for arPTE and 
[arPTE][S+][S−] (Figure S4A), which indicated that surfactant complexation did not affect the 
secondary structure. This suggests that the rate enhancement did not occur via fortuitous 
stabilization of a structural conformation, although conformational changes beyond the 
resolution of CD cannot be discounted. 
The observed catalytic efficiency of many enzymes are dependent on other extraneous 
contributions, such as surface-induced deactivation.(28) This effect can be significant when 
Figure 3. a) The pair-distance distribution function 
(P(r)) of arPTE (blue) and [arPTE][S+][S−] (red) 
obtained through SR-SAXS. The surfactant 
conjugation process increases the radial average 
(rave) of the enzyme from 36.2 Å to 48.8 Å. b) The 
crystal structure of arPTE (PDB ID: 2D2J, purple) 
superimposed on the bead-model obtained from 
SR-SAXS analysis of arPTE (green) and 
[arPTE][S+][S−] (blue). The models confirm that the 
oligomeric state of the enzyme is still maintained 
after conjugation with the surfactant corona, and that 






working with enzymes at very low concentrations, as is necessary to collect the linear initial 
rate for highly efficient enzymes such as arPTE. Experimentally, these adsorption effects can 
be prevented with the addition of bovine serum albumin (BSA) to block non-specific protein 
binding.(29) Accordingly, both arPTE and [arPTE][S+][S−] were assayed against paraoxon with 
and without the presence of 0.1% w/v BSA. The addition BSA did not initially result in a change 
in the catalytic activity in either system (assay periods < 10 minutes) (Figure 4A). However, 
assays performed over a four-hour period showed a gradual decay in the activity of arPTE, 
which did not occur for [arPTE][S+][S−], [arPTE][S+][S−] with 0.1% w/v BSA, and arPTE with 
0.1% w/v BSA (Figure 4B). To investigate if the loss in activity of the native enzyme was due 
to slow unfolding (rather than surface-induced deactivation), a time-dependent circular 
dichroism thermostability study of arPTE and [arPTE][S+][S−] was performed (Figures S4B-
C). While a high-temperature CD gradient did show that [arPTE][S+][S−] had a slight 
enhancement to overall thermostability, an isothermal time-course experiment at 40 C   
showed that no slow denaturation of either [arPTE][S+][S−] or arPTE occurs even at 
temperatures elevated slightly above ambient conditions. Accordingly, this data supports a 
scenario where either the surfactant corona or BSA stabilised the enzyme, and where the 
presence of BSA did not enhance the activity of the enzyme, but rather, prevented the loss of 
activity over time. Moreover, this loss of activity would only be significant for assays conducted 
over long time periods, and therefore could only represent a small fraction of the improvement 
in the catalytic efficiency observed for [arPTE][S+][S−]. 
 
 
Figure 4. a) The normalized catalytic rate 
(kcat) of arPTE and [arPTE][S+][S−] at room 
temperature with and without the presence of 
0.1% w/v BSA, showing that BSA itself does 
not appear to directly influence catalytic rate. 
b) Activity of a stock of 4 nM enzyme over 
time at room temperature, showing that 
hydrophobic denaturation can significantly 
affect the observed rate of arPTE (blue) over 
extended periods of time. arPTE with BSA 
(red), [arPTE][S+][S−] (green) and 
[arPTE][S+][S−] with BSA (purple) do not 
exhibit this loss in activity. All assays were 
performed as described in the 
supplementary methods in  a buffer of 30 mM 





Previous studies of PTEs have established that the rate limiting step of these high turnover 
rate enzymes is the diffusion of the reaction product away from the active site.(30) It is 
therefore possible that the formation of a compact amphiphilic polymer-surfactant corona may 
accelerate the diffusion step via product partitioning through a reduction in the local dielectric 
constant at the active site. This mechanism is supported by the conserved tertiary and 
secondary structure reported above (verified through SAXS and CD respectively), and the 
positive correlation between the molecular weight of the surfactant and the enzymatic activity. 
This is not unprecedented, as an increase in activity has previously been noted post-
modification of PTEs,(31) with an in-depth study of PTE nanoparticle complexes also showing 
an increase in activity.(32, 33) The authors attributed this to an increase in the diffusion of the 
product away from the active site, promoted by a change in the immediate microenvironment 
around the enzyme. Using the same theoretical model as Breger et al. that considers changes 
in substrate and product on and off rates,(32) we show that our experimentally observed data 
is consistent with an increase to the product release/diffusion step, rather than a substrate 
binding step (Figure S5). Finally, we observe that compared to paraoxon, the magnitude of 
the rate enhancement is larger for coumaphos (Figures S6A-B), a substrate with a more 
hydrophobic product, further supporting the theory that diffusion of hydrophobic products is 
better enabled by the amphiphilic corona. Enzyme enhancement through substrate/product 
partitioning has been previously described, but through enzyme immobilization,(34) thus the 
retention of enzyme mobility is an important outcome. However, as alterations to the surface 
of arPTE can have impact on activity,(30, 35) we cannot discount the possibility that there is 
some fortuitous enhancement of conformational mobility, resulting in an increase in the rate 
of product release. An additional consideration is a change in the oligomeric equilibrium 
between the monomer and dimer influencing the catalytic rate, however as we see a difference 
in the rate enhancement between different substrates, this is unlikely. 
To further probe the effect of polymer surfactant complexation on enzyme structure 
and function, the dual surfactant complexation method was applied to three other PTEs: 
pdPTE-C23, α-Esterase7 (αEst7) and DFPase (Figure S7A–C).(36-38) Phosphotriesterase-
C23 (pdPTE-C23) is a PTE mutant from Pseudomonas diminuta designed for greater catalytic 
efficiency against the G and V series nerve agents.(36) αEst7 is a carboxylesterase that has 
evolved independently to break down a number of organophosphate pesticides and is 
structurally distinct from the PTE enzyme superfamily.(37) Lastly, DFPase, found in Loligo 
vulgaris, is capable of hydrolysing diisopropylfluorophosphate (DFP), and like αEst7, is 
structurally distinct.(38) All three enzymes successfully formed enzymatically active polymer 
surfactant-complexes through the dual-surfactant method. As with [arPTE][S+][S−], SR-SAXS 
confirmed the formation of discrete enzyme-polymer surfactant complexes with compact 
coronas (Figures S7D–F). Interestingly, polymer-surfactant complexation resulted in a 
decrease in kcat and an increase in Km for pdPTE-C23 and αEst7. As αEst7 has evolved to 
hydrolyse fatty ester substrates akin to the hydrophobic tails of the surfactant, this is likely a 
consequence of steric inhibition of the active site.(15, 24) In a similar fashion, pdPTE-C23 has 
an engineered mutation of a phenylalanine residue to a glutamate (F132E) at the active 
site,(36) which would promote inhibition via electrostatic binding of S+. To confirm that the 
observed inhibition was not due to denaturation and was a result of active site inhibition, we 
also assayed the activity after treating pdPTE-C23 with uncharged surfactants. As expected, 
at high surfactant concentrations (1% w/v of assay) pdPTE-C23 showed inhibition comparable 
to [pdPTE-C23][S-] (Figure S8). However after dialysis, activity was restored to pdPTE-C23 
treated with uncharged surfactants, but not for [pdPTE-C23][S-]. This demonstrates that the 
decreased rate is through active site inhibition by the surfactant, and also verifies that the 
surfactant corona complex is maintained even at dilute concentrations. Finally, for DFPase we 




[DFPase][S+][S−]. As the rate limiting step of DFPase is the dissociation of fluorine from the 
phosphorous during the catalytic cycle,(38) the lack of rate enhancement (or decrease) 
observed here supports our proposed mechanism of improved product off rate.  
In conclusion, we have demonstrated that our electrostatic dual surfactant conjugation 
methodology can be readily applied to generate aqueous molecular dispersion of active 
enzyme-polymer surfactant complexes without the need for covalent modifications. Moreover, 
we show that the approach can be tuned to enhance the catalytic efficiency of arPTE by more 
than three-fold, and we reconcile this improvement with an acceleration in the product diffusion 
rate via hydrophobic partitioning. We also show that the surface-bound polymer surfactant 
corona protects arPTE from surface-induced deactivation. Although we could readily apply our 
methodology to other PTEs to give catalytically active complexes, it is clear that rate 
enhancement is dependent on parameters such as catalytic mechanism, surface charge, 
hydrophobicity and active site geometry. In principle, the use of amphiphilic coronas is 
compatible with other beneficial enzyme modifications such as immobilization. The covalent 
linkage of the surfactant or the enzyme to a surface may impart properties such as improved 
selectivity,(34) and may enhance the enzyme beyond what is achievable through simple 
immobilization alone, but at the cost of enzyme mobility. With the correct selection of polymer-
surfactants and rational enzyme design, it should be possible to improve the performance of 
industrially-relevant enzymes under both aqueous and non-aqueous conditions.(39, 40) 
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